A new trial in France for soft tissue sarcoma:
http://www.nanobiotix.com/news/release/nanobiotix-starts-clinical-trial-with-lead-product-nbtxr3/
A new trial in France for soft tissue sarcoma:
http://www.nanobiotix.com/news/release/nanobiotix-starts-clinical-trial-with-lead-product-nbtxr3/
Nanobiotix has received approval to start the phase II/III trial: